Onconetix, Inc.
ONCO
$0.0761
-$0.0039-4.88%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.87M | 1.46M | 758.90K | 58.50K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.87M | 1.46M | 758.90K | 58.50K | -- |
| Cost of Revenue | 2.60M | 2.30M | 1.70M | 1.19M | -- |
| Gross Profit | -732.10K | -837.50K | -938.20K | -1.13M | -- |
| SG&A Expenses | 13.07M | 14.69M | 14.77M | 12.80M | 10.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.62M | 17.06M | 17.39M | 15.94M | 13.73M |
| Operating Income | -13.75M | -15.60M | -16.63M | -15.88M | -13.73M |
| Income Before Tax | -51.74M | -53.21M | -45.82M | -37.42M | -18.28M |
| Income Tax Expenses | -139.80K | -83.40K | -134.20K | -12.60K | -- |
| Earnings from Continuing Operations | -51.60 | -53.12 | -45.68 | -37.41 | -18.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.60M | -53.12M | -45.68M | -37.41M | -18.28M |
| EBIT | -13.75M | -15.60M | -16.63M | -15.88M | -13.73M |
| EBITDA | -13.10M | -15.15M | -16.38M | -15.84M | -13.73M |
| EPS Basic | -95.63 | -104.90 | -96.39 | -83.46 | -44.55 |
| Normalized Basic EPS | -11.45 | -16.97 | -19.43 | -19.41 | -21.65 |
| EPS Diluted | -95.63 | -104.90 | -96.39 | -83.46 | -44.55 |
| Normalized Diluted EPS | -11.45 | -16.97 | -19.43 | -19.41 | -21.65 |
| Average Basic Shares Outstanding | 2.89M | 2.02M | 1.87M | 1.71M | 1.64M |
| Average Diluted Shares Outstanding | 2.89M | 2.02M | 1.87M | 1.71M | 1.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |